Clinical Trial Update: A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis. [Phase 2]

View source ↗

Summary

Phase II trial in adults with moderate to severe active ulcerative colitis completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Snippet

Sponsor: Reistone Biopharma Company Limited | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED | Results posted: 2022-11-22